Zero tolerance for drug trade in any form in Maharashtra: CM Shinde | Politics News

Palantir's management has the opportunity to buy back over $900 million of its own stock but has not yet taken advantage of this option. The stock prices referenced are from the afternoon of May 29, 2025, and the video discussing this matter was published on May 31, 2025. This situation raises questions about the company's confidence in its stock value and future market performance. Full Article

Runway Reopening at Newark Liberty International AirportNewark Liberty International Airport will reopen a runway on Monday that had been under construction, which contributed to the airport's recent operational chaos. This move comes as United Airlines (UAL) aims to regain the trust of customers who have begun avoiding the troubled airport. The reopening of the runway is a strategic step to improve the airport's functionality and enhance passenger experience. Full Article

Despite the volatility in broader equities this year, investing in stocks remains wise, as holding shares of leading companies for five years often yields superior returns. In the biotech sector, two companies to consider are CRISPR Therapeutics (NASDAQ: CRSP) and Regeneron Pharmaceuticals (NASDAQ: REGN), both of which have experienced significant share declines over the past year but may offer substantial upside for patient investors. This highlights the importance of long-term investment strategies, even during uncertain...

The tech sector has historically benefited patient investors, with companies like Apple, Microsoft, and Amazon providing substantial returns. Currently, three additional resilient blue-chip tech stocks—Nvidia (NASDAQ: NVDA), Meta Platforms (NASDAQ: META), and Palo Alto Networks (NASDAQ: PANW)—are highlighted as potential market-beaters for long-term investors who adopt a buy-and-hold strategy. These companies may yield impressive gains for those willing to overlook short-term market fluctuations and focus on a decade-long investment horizon. Full Article

Nvidia (NASDAQ: NVDA) reported a record-breaking quarter, with $44.1 billion in revenue for the first quarter of fiscal 2026, marking a 69% year-over-year increase and a 12% rise from the previous quarter. The company's net income reached $18.8 billion, a 26% increase year over year, even after incurring a $4.5 billion charge due to new U.S. export restrictions. Despite the strong financial performance, geopolitical pressures and tariff uncertainties raise questions for long-term investors regarding whether...

Nvidia (NASDAQ: NVDA) has seen remarkable gains of over 1,400% in the past five years, driven by its leading role in the artificial intelligence (AI) sector and substantial earnings growth, with revenue consistently rising in double or triple digits. However, concerns about import tariffs and AI chip export restrictions to China led to a 29% decline in the stock from January to its lowest point in April. Recently, Nvidia's stock has rebounded amid improving tariff...